| pubmed-article:1527502 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1527502 | lifeskim:mentions | umls-concept:C0315170 | lld:lifeskim |
| pubmed-article:1527502 | lifeskim:mentions | umls-concept:C1511758 | lld:lifeskim |
| pubmed-article:1527502 | lifeskim:mentions | umls-concept:C0679622 | lld:lifeskim |
| pubmed-article:1527502 | lifeskim:mentions | umls-concept:C0205314 | lld:lifeskim |
| pubmed-article:1527502 | pubmed:dateCreated | 1992-10-19 | lld:pubmed |
| pubmed-article:1527502 | pubmed:abstractText | A Comamonas acidovorans strain, designated NBA-10, was isolated on 4-nitrobenzoate as sole carbon and energy source. When grown on 4-nitrobenzoate, it was simultaneously adapted to 4-nitrosobenzoate and 4-hydroxylaminobenzoate but not to 4-hydroxybenzoate or 4-aminobenzoate. In cell extracts with NADPH present, 4-nitrobenzoate was degraded to 4-hydroxylaminobenzoate and 3,4-dihydroxybenzoate. Partial purification of the 4-nitrobenzoate reductase revealed that 4-nitrobenzoate is degraded via 4-nitrosobenzoate to 4-hydroxylamino-benzoate. The substrate specificity of the enzyme was narrow and NADPH was 15 times more effective as a cofactor than NADH. The results provide evidence for a novel pathway for aerobic degradation of 4-nitrobenzoate, since neither 4-hydroxybenzoate nor 4-aminobenzoate were involved in the degradative pathway. | lld:pubmed |
| pubmed-article:1527502 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1527502 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1527502 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1527502 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1527502 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1527502 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1527502 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1527502 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1527502 | pubmed:month | Aug | lld:pubmed |
| pubmed-article:1527502 | pubmed:issn | 0022-1287 | lld:pubmed |
| pubmed-article:1527502 | pubmed:author | pubmed-author:de BontJ AJA | lld:pubmed |
| pubmed-article:1527502 | pubmed:author | pubmed-author:GroenewegenP... | lld:pubmed |
| pubmed-article:1527502 | pubmed:author | pubmed-author:van... | lld:pubmed |
| pubmed-article:1527502 | pubmed:author | pubmed-author:BreeuwerPP | lld:pubmed |
| pubmed-article:1527502 | pubmed:author | pubmed-author:LangenhoffA... | lld:pubmed |
| pubmed-article:1527502 | pubmed:author | pubmed-author:de VriesF PFP | lld:pubmed |
| pubmed-article:1527502 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1527502 | pubmed:volume | 138 Pt 8 | lld:pubmed |
| pubmed-article:1527502 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1527502 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1527502 | pubmed:pagination | 1599-605 | lld:pubmed |
| pubmed-article:1527502 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:1527502 | pubmed:meshHeading | pubmed-meshheading:1527502-... | lld:pubmed |
| pubmed-article:1527502 | pubmed:meshHeading | pubmed-meshheading:1527502-... | lld:pubmed |
| pubmed-article:1527502 | pubmed:meshHeading | pubmed-meshheading:1527502-... | lld:pubmed |
| pubmed-article:1527502 | pubmed:meshHeading | pubmed-meshheading:1527502-... | lld:pubmed |
| pubmed-article:1527502 | pubmed:meshHeading | pubmed-meshheading:1527502-... | lld:pubmed |
| pubmed-article:1527502 | pubmed:meshHeading | pubmed-meshheading:1527502-... | lld:pubmed |
| pubmed-article:1527502 | pubmed:year | 1992 | lld:pubmed |
| pubmed-article:1527502 | pubmed:articleTitle | Novel degradative pathway of 4-nitrobenzoate in Comamonas acidovorans NBA-10. | lld:pubmed |
| pubmed-article:1527502 | pubmed:affiliation | Department of Food Science, Agricultural University, Wageningen, The Netherlands. | lld:pubmed |
| pubmed-article:1527502 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1527502 | lld:pubmed |
